SCHEMBL4916319

SCHEMBL4916319

[c]1ccc2cccc3c2c1-c1c-3c(-c2ccccc2)c2ccccc2c1-c1ccccc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP1 P22413 2/20 0.35
ALDH1A1 P00352 5/20 0.33
HSD17B10 Q99714 5/20 0.33
MAPK1 P28482 5/20 0.33
L3MBTL1 Q9Y468 4/20 0.33
TSHR P16473 4/20 0.33
ATM Q13315 2/20 0.33
SIGMAR1 Q99720 1/20 0.33
CDK4 P11802 1/20 0.33
CCND1 P24385 1/20 0.33
HPGD P15428 4/20 0.32
CYP1A2 P05177 1/20 0.32
THRB P10828 1/20 0.32
KDM4E B2RXH2 2/20 0.32
MAPT P10636 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
TP53 P04637 2/20 0.32
NFKB1 P19838 1/20 0.32
NFKB2 Q00653 1/20 0.32
RELA Q04206 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4917817 0.92 ALDH1A1 (0.36) ALDH1A1HSD17B10MAPK1L3MBTL1TSHR
SCHEMBL18221935 0.85 ALDH1A1 (0.42) ALDH1A1HSD17B10MAPK1L3MBTL1TSHR
SCHEMBL30155046 0.82 ALDH1A1 (0.50) ENPP1ALDH1A1HSD17B10MAPK1L3MBTL1
SCHEMBL503284 0.82 ALDH1A1 (0.50) ENPP1ALDH1A1HSD17B10MAPK1L3MBTL1
SCHEMBL4912279 0.80 ALDH1A1 (0.41) ALDH1A1HSD17B10MAPK1L3MBTL1TSHR
SCHEMBL454555 0.75 DNMT1 (0.45) ALDH1A1HSD17B10MAPK1L3MBTL1TSHR
SCHEMBL454556 0.75 DNMT1 (0.41) ALDH1A1HSD17B10MAPK1L3MBTL1TSHR
SCHEMBL4912272 0.75 MAPK1 (0.40) ALDH1A1HSD17B10MAPK1L3MBTL1TSHR
SCHEMBL13911239 0.73 TNF (0.47) ENPP1ALDH1A1HSD17B10MAPK1L3MBTL1
SCHEMBL13085133 0.73 ALDH1A1 (0.45) ENPP1ALDH1A1HSD17B10MAPK1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080122344-A1 ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME, AND METHOD OF MANUFACTURING THE ORGANIC LIGHT EMITTING DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2008-05-29 US claimed
US-20080122344-A1 ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME, AND METHOD OF MANUFACTURING THE ORGANIC LIGHT EMITTING DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2008-05-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080122344-A1 ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME, AND METHOD OF MANUFACTURING THE ORGANIC LIGHT EMITTING DEVICE CYBA, CRY2, LAS1L ENPP1 999/4885ALDH1A1 70/4885HSD17B10 2603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.